Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) EBIT: 2013-2024

Historic EBIT for Wave Life Sciences (WVE) over the last 12 years, with Dec 2024 value amounting to -$110.4 million.

  • Wave Life Sciences' EBIT rose 11.83% to -$56.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$135.9 million, marking a year-over-year increase of 10.59%. This contributed to the annual value of -$110.4 million for FY2024, which is 62.37% down from last year.
  • As of FY2024, Wave Life Sciences' EBIT stood at -$110.4 million, which was down 62.37% from -$68.0 million recorded in FY2023.
  • Wave Life Sciences' 5-year EBIT high stood at -$68.0 million for FY2023, and its period low was -$162.7 million during FY2022.
  • Over the past 3 years, Wave Life Sciences' median EBIT value was -$110.4 million (recorded in 2024), while the average stood at -$113.7 million.
  • In the last 5 years, Wave Life Sciences' EBIT skyrocketed by 58.21% in 2023 and then plummeted by 62.37% in 2024.
  • Yearly analysis of 5 years shows Wave Life Sciences' EBIT stood at -$153.4 million in 2020, then rose by 17.19% to -$127.0 million in 2021, then dropped by 28.11% to -$162.7 million in 2022, then surged by 58.21% to -$68.0 million in 2023, then slumped by 62.37% to -$110.4 million in 2024.